# OnCo record nct00002786 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00002786/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00002786", "NCT00002786" ;
  schema:name "Tyrosinase-specific CD8+ T cells, gene-modified and unmodified, in metastatic melanoma (Fred Hutchinson phase 1/2)"@en ;
  schema:description "An early Seattle trial that gave people with melanoma that had spread their own T cells grown to recognise tyrosinase, a melanoma protein. It started in 1995 and the registry lists it as completed in 2006."@en ;
  schema:url <https://onco.cc/trials/nct00002786/> ;
  schema:dateModified "2026-11-05"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00002786> ;
  onco:status "completed" ;
  onco:phase "1/2" ;
  schema:startDate "1995-10" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:targets <https://onco.cc/targets/tyr/> ;
  onco:drugs <https://onco.cc/drugs/aldesleukin/> ;
  onco:institutions <https://onco.cc/institutions/fred-hutch/>, <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/endogenous-t-cell-therapy/> ;
  onco:people <https://onco.cc/people/cassian-yee/> .